Showing results (111-120 of 121) with videos related to
Sort By:
Pageof 13
American Heart Journal|November 2, 2025
Routine versus selective protamine administration to reduce bleeding after TAVI: Rationale and design of the POPular ACE TAVI trialDaniël C Overduin, Dirk Jan van Ginkel, Christophe Dubois, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 13, 2026
Extremity Function After Transfemoral Transcatheter Aortic Valve Implantation: A TAVI XS Sub-StudyGeert A A Versteeg, Maxim J P Rooijakkers, Kimberley I Hemelrijk, et al.Journal of the American College of Cardiology|October 29, 2025
PCI of Native Coronary Artery vs Saphenous Vein Graft After Prior Bypass Surgery: A Multicenter, Randomized TrialRuben W de Winter, Roel Hoek, Simon J Walsh, et al.American Heart Journal|December 14, 2024
Deferral of routine percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation: Rationale and design of the PRO-TAVI trialHugo M Aarts, Kimberley I Hemelrijk, Gijs M Broeze, et al.Journal of the American Heart Association|May 14, 2026
Surgical Versus Transcatheter Aortic Valve Replacement in Bicuspid Aortic Stenosis: 1-Year Clinical Outcomes in Patients Aged 65 Years and OlderKimberley Iris Hemelrijk, Matias R Mon Noboa, Gabriela Tirado-Conte, et al.The New England Journal of Medicine|March 31, 2020
Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve ImplantationVincent J Nijenhuis, Jorn Brouwer, Ronak Delewi, et al.The New England Journal of Medicine|September 1, 2020
Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve ImplantationJorn Brouwer, Vincent J Nijenhuis, Ronak Delewi, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 22, 2023
Periprocedural continuation versus interruption of oral anticoagulant drugs during transcatheter aortic valve implantation: rationale and design of the POPular PAUSE TAVI trialDirk Jan van Ginkel, Willem L Bor, Christophe L F Dubois, et al.American Heart Journal|November 2, 2025
Rationale and design of REAC-TAVI 2: Single antiplatelet treatment with ticagrelor vs aspirin after transcatheter aortic valve implantationKimberley I Hemelrijk, Victor A Jimenez-Diaz, Jean Paul Vilchez, et al.The New England Journal of Medicine|August 31, 2024
Continuation versus Interruption of Oral Anticoagulation during TAVIDirk Jan van Ginkel, Willem L Bor, Hugo M Aarts, et al.Pageof 13